315 results
Page 8 of 16
8-K
EX-1.1
t19sg0xi9khc8s 33
16 Mar 12
Discovery Labs Prices $45.0 Million Public Offering of
12:00am
8-K
mjs1uxmj1rlcwuxlcd
16 Mar 12
Discovery Labs Prices $45.0 Million Public Offering of
12:00am
424B5
uilbbz0as 4y0
15 Mar 12
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
1asy 22g1
7 Mar 12
Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) for Prevention of Respiratory Distress Syndrome
12:00am
424B5
3ddnz
15 Dec 11
Prospectus supplement for primary offering
12:00am
8-K
EX-10.1
8aph4d4e b2k
14 Dec 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
y3j6m48
28 Sep 11
Other Events
12:00am
8-K
EX-99.1
06xalavs9nu
6 Sep 11
Discovery Labs Submits SURFAXIN® Complete Response to FDA
12:00am
8-K
lzkoky2vevfzeix
29 Jul 11
Other Events
12:00am
8-K
EX-99.1
vghr 1a0yput
29 Jul 11
Other Events
12:00am
8-K
EX-99.1
h1rk0ddogk
1 Jun 11
Other Events
12:00am
424B5
6zt8fr 0mkjgv
17 Feb 11
Prospectus supplement for primary offering
12:00am
8-K
EX-1.1
mw1ndc
16 Feb 11
Discovery Labs Prices $23.5 Million Public Offering of
12:00am
424B5
j675c9qzpph30fd2qgt
15 Feb 11
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
4jyazew43qloo70t
9 Feb 11
Other Events
12:00am